• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化的CD27⁺PD-1⁺ CD8⁺ T细胞和CD4⁺调节性T细胞在难治性II型乳糜泻的肿瘤微环境中占主导地位。

Activated CD27PD-1 CD8 T Cells and CD4 T Regulatory Cells Dominate the Tumor Microenvironment in Refractory Celiac Disease Type II.

作者信息

Dieckman Tessa, Schreurs Mette, Lindelauf Ciska, Mahfouz Ahmed, Meijer Caroline R, Pigeaud Louise, van Unen Vincent, Bouma Gerd, Koning Frits

机构信息

Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands.

Department of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, the Netherlands.

出版信息

Gastro Hep Adv. 2024 Sep 4;4(1):100545. doi: 10.1016/j.gastha.2024.08.023. eCollection 2025.

DOI:10.1016/j.gastha.2024.08.023
PMID:39802487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11719358/
Abstract

BACKGROUND AND AIMS

Refractory celiac disease type II (RCDII) is characterized by a clonally expanded aberrant cell population in the small intestine. The role of other tissue-resident immune subsets in RCDII is unknown. Here, we characterized CD8 and CD4 T cells in RCDII duodenum at the single-cell level and .

METHODS

We applied mass cytometry on CD45 duodenal cells derived from intestinal biopsies (n = 23) and blood samples (n = 20) from RCDII patients and controls. Additionally, we analyzed intestinal biopsies from celiac disease (n = 11) and RCDI (n = 2) patients. We performed single-cell RNA-sequencing on CD45 duodenal cells derived from a RCDII patient, immunofluorescence staining for analysis and flow cytometry for phenotyping of RCDII aberrant and CD8 T cells.

RESULTS

Compared to healthy controls, we observed that CD27PD-1 memory CD8αβ cells and CD4 T regulatories (Tregs) were more abundant in RCDII duodenum (CD8 ∗∗0.0029; CD4 ∗∗∗0.0001). The CD27PD-1 memory CD8αβ cells expressed the tissue-resident marker CD69, immunoregulatory markers (, NKG2A, were enriched for activated pathways and displayed cytotoxic gene signatures (. The absence of CD103 accords with their localization in the lamina propria as determined by analysis. The CD25FoxP3CD27CD127 CD4 Tregs expressed and and costimulatory molecules (, and ) and resided in the lamina propria as well. Flow cytometry confirmed the presence of the inhibitory receptor NKG2A on expanded duodenal CD8 T cells and HLA-E, the ligand for NKG2A, on expanded aberrant cells.

CONCLUSION

RCDII is characterized by the simultaneous presence of an activated CD27PD-1 memory CD8αβ T cell subset and CD4 Tregs, suggesting that checkpoint blockade with anti-NKG2A/PD-1 and/or anticytotoxic T lymphocyte antigen 4 may be an attractive treatment option.

摘要

背景与目的

II型难治性乳糜泻(RCDII)的特征是小肠中存在克隆性扩增的异常细胞群。其他组织驻留免疫亚群在RCDII中的作用尚不清楚。在此,我们在单细胞水平上对RCDII十二指肠中的CD8和CD4 T细胞进行了特征分析。

方法

我们对来自RCDII患者和对照的肠道活检组织(n = 23)和血液样本(n = 20)中的CD45十二指肠细胞进行了质谱流式细胞术分析。此外,我们分析了乳糜泻患者(n = 11)和I型难治性乳糜泻(RCDI)患者(n = 2)的肠道活检组织。我们对来自一名RCDII患者的CD45十二指肠细胞进行了单细胞RNA测序,进行了免疫荧光染色以进行分析,并通过流式细胞术对RCDII异常细胞和CD8 T细胞进行表型分析。

结果

与健康对照相比,我们观察到RCDII十二指肠中CD27PD-1记忆性CD8αβ细胞和CD4调节性T细胞(Tregs)更为丰富(CD8 **0.0029;CD4 ***0.0001)。CD27PD-1记忆性CD8αβ细胞表达组织驻留标志物CD69,免疫调节标志物(,NKG2A)富含活化途径并显示细胞毒性基因特征(。缺乏CD103与其在固有层中的定位一致,这是通过分析确定的。CD25FoxP3CD27CD127 CD4 Tregs表达 和 以及共刺激分子(, 和 ),并且也存在于固有层中。流式细胞术证实扩增的十二指肠CD8 T细胞上存在抑制性受体NKG2A,并且扩增的异常细胞上存在NKG2A的配体HLA-E。

结论

RCDII的特征是同时存在活化的CD27PD-1记忆性CD8αβ T细胞亚群和CD4 Tregs,这表明用抗NKG2A/PD-1和/或抗细胞毒性T淋巴细胞抗原4进行检查点阻断可能是一种有吸引力的治疗选择。

相似文献

1
Activated CD27PD-1 CD8 T Cells and CD4 T Regulatory Cells Dominate the Tumor Microenvironment in Refractory Celiac Disease Type II.活化的CD27⁺PD-1⁺ CD8⁺ T细胞和CD4⁺调节性T细胞在难治性II型乳糜泻的肿瘤微环境中占主导地位。
Gastro Hep Adv. 2024 Sep 4;4(1):100545. doi: 10.1016/j.gastha.2024.08.023. eCollection 2025.
2
Single-Cell Analysis of Refractory Celiac Disease Demonstrates Inter- and Intra-Patient Aberrant Cell Heterogeneity.单细胞分析难治性乳糜泻显示出患者间和患者内异常细胞异质性。
Cell Mol Gastroenterol Hepatol. 2022;14(1):173-192. doi: 10.1016/j.jcmgh.2022.03.005. Epub 2022 Mar 23.
3
Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II.识别难治性乳糜泻 II 型中异常细胞的潜在生理前体。
Gut. 2013 Apr;62(4):509-19. doi: 10.1136/gutjnl-2012-302265. Epub 2012 Jul 3.
4
CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes.CD4 T细胞细胞因子协同作用,诱导恶性和非恶性先天性上皮内淋巴细胞增殖。
Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E980-E989. doi: 10.1073/pnas.1620036114. Epub 2017 Jan 3.
5
Origin and immunophenotype of aberrant IEL in RCDII patients.RCDII 患者异常 IEL 的来源和免疫表型。
Mol Immunol. 2012 Apr;50(4):262-70. doi: 10.1016/j.molimm.2012.01.014. Epub 2012 Feb 23.
6
The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease.乳糜泻患者十二指肠上皮固有淋巴细胞区的组成和分化潜能发生改变。
Gut. 2016 Aug;65(8):1269-78. doi: 10.1136/gutjnl-2014-308153. Epub 2015 May 12.
7
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.
8
Therapy in RCDII: Rationale for Combination Strategies?RCDII中的治疗:联合策略的理论依据?
Dig Dis. 2015;33(2):227-230. doi: 10.1159/000381076. Epub 2015 Apr 22.
9
A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease.位于7p14.3的一个基因座使乳糜泻易发展为难治性乳糜泻。
Eur J Gastroenterol Hepatol. 2018 Aug;30(8):828-837. doi: 10.1097/MEG.0000000000001168.
10
Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.树突状细胞促进难治性乳糜泻 II 型患者异常 TCR 阴性上皮内淋巴细胞系的扩增和存活。
Mol Immunol. 2014 Mar;58(1):10-6. doi: 10.1016/j.molimm.2013.10.014. Epub 2013 Nov 16.

引用本文的文献

1
Malignancies in Celiac Disease-A Hidden Threat with Diagnostic Pitfalls.乳糜泻相关恶性肿瘤——存在诊断陷阱的隐匿威胁
Biomedicines. 2025 Jun 19;13(6):1507. doi: 10.3390/biomedicines13061507.
2
Lactiplantibacillus plantarum Moderating Effect on Autoimmune Celiac Disease Triggers.植物乳杆菌对自身免疫性乳糜泻触发因素的调节作用。
Probiotics Antimicrob Proteins. 2025 Mar 19. doi: 10.1007/s12602-025-10514-5.

本文引用的文献

1
Single-Cell Analysis of Refractory Celiac Disease Demonstrates Inter- and Intra-Patient Aberrant Cell Heterogeneity.单细胞分析难治性乳糜泻显示出患者间和患者内异常细胞异质性。
Cell Mol Gastroenterol Hepatol. 2022;14(1):173-192. doi: 10.1016/j.jcmgh.2022.03.005. Epub 2022 Mar 23.
2
The CD70-CD27 axis in oncology: the new kids on the block.肿瘤学中的 CD70-CD27 轴:崭露头角的新势力。
J Exp Clin Cancer Res. 2022 Jan 6;41(1):12. doi: 10.1186/s13046-021-02215-y.
3
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division.
NKG2A 是 CD8 T 细胞上的晚期免疫检查点,标志着反复的刺激和细胞分裂。
Int J Cancer. 2022 Feb 15;150(4):688-704. doi: 10.1002/ijc.33859. Epub 2021 Nov 10.
4
Not-so-opposite ends of the spectrum: CD8 T cell dysfunction across chronic infection, cancer and autoimmunity.处于光谱两端的不典型情况:慢性感染、癌症和自身免疫中 CD8 T 细胞功能障碍。
Nat Immunol. 2021 Jul;22(7):809-819. doi: 10.1038/s41590-021-00949-7. Epub 2021 Jun 17.
5
Oncogenetic landscape of lymphomagenesis in coeliac disease.腹腔疾病相关淋巴瘤发病的oncogenetic 图谱。
Gut. 2022 Mar;71(3):497-508. doi: 10.1136/gutjnl-2020-322935. Epub 2021 Feb 12.
6
Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II.难治性乳糜泻 II 型的免疫表型谱和基因组特征
Am J Surg Pathol. 2021 Jul 1;45(7):905-916. doi: 10.1097/PAS.0000000000001658.
7
Helpless Priming Sends CD8 T Cells on the Road to Exhaustion.无助的初始激活使 CD8 T 细胞走向衰竭。
Front Immunol. 2020 Oct 6;11:592569. doi: 10.3389/fimmu.2020.592569. eCollection 2020.
8
New emerging targets in cancer immunotherapy: CD27 (TNFRSF7).癌症免疫治疗的新新兴靶点:CD27(TNFRSF7)。
ESMO Open. 2020 Mar;4(Suppl 3):e000629. doi: 10.1136/esmoopen-2019-000629.
9
Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method.使用统一的免疫组织化学方法对多种实体瘤和血液肿瘤类型进行CD70表达筛查,作为潜在的患者分层方法。
Cancers (Basel). 2019 Oct 22;11(10):1611. doi: 10.3390/cancers11101611.
10
Monalizumab: inhibiting the novel immune checkpoint NKG2A.莫那比拉珠单抗:抑制新型免疫检查点 NKG2A。
J Immunother Cancer. 2019 Oct 17;7(1):263. doi: 10.1186/s40425-019-0761-3.